Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products (U01) Clinical Trials Not Allowed

The Food and Drug Administration (FDA) announces its intention to accept and consider a single source application for award of a Cooperative Agreement to the World Health Organization (WHO) in support of collaboration in regulatory systems strengthening, development of norms and standards, and innovative


research to advance global access to safe and effective biological products that meet international standards.
Related Programs

Food and Drug Administration_Research

Department of Health and Human Services


Agency: Department of Health and Human Services

Office: Food and Drug Administration

Estimated Funding: $10,000,000


Relevant Nonprofit Program Categories





Obtain Full Opportunity Text:
Full Announcement of RFA-FD-21-031 on NIH Guide for Grants and Contracts

Additional Information of Eligibility:
The World Health Organization (WHO)

Full Opportunity Web Address:
https://grants.nih.gov/grants/guide/rfa-files/RFA-FD-21-031.html

Contact:


Agency Email Description:
gordana.zuber@fda.hhs.gov

Agency Email:


Date Posted:
2021-04-12

Application Due Date:


Archive Date:
2021-08-12


Chief executive of HCT, Dai Powell, shares the experiences and practical lessons he learned along the way when teaming up with Ealing Community Transport to deliver site transport during the Olympic Park construction.






More Federal Domestic Assistance Programs


Development and Coordination of Rural Health Services | National Security Education Program David L. Boren Scholarships | Environmental Justice Collaborative Problem-Solving Cooperative Agreement Program | State Health Insurance Assistance Program | Section 8 Moderate Rehabilitation Single Room Occupancy |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders

© 2004-2024 Copyright Michael Saunders